Tbilisi Finance Summit registration closes inRegistration closes in

Apply to attendApply to attend

2026 Speakers

All speakers
Joshua Fink

Joshua Fink

Founder & Managing Member

Luma Group

Josh Fink is a seasoned investor, leader and philanthropist who leads Luma Group’s vision to drive scientific breakthroughs at the intersection of healthcare, biotechnology and advanced computational technologies. He directs the firm’s flagship fund, LumaBio I, investing in early- and mid-stage companies leveraging AI, machine learning and data-driven tools to accelerate life sciences discovery. With over two decades of investment experience, Josh sources proprietary opportunities, evaluates transactions and supports portfolio companies as they scale.

In addition to leading investment strategy, Josh plays a hands-on role in fundraising, chairs the investment committee and helps shape the strategic direction of the firm’s portfolio. He is instrumental in building partnerships across pharmaceutical companies, research institutions and the broader healthcare innovation ecosystem. He is also a founding investor and senior advisor to Altos Labs and National Resilience and was an early investor and advisor to Digital Surgery, which was acquired by Medtronic.

Speaking At

  • 3:40–4:00pmTue 27 OctSummit StageKavkasioni Ballroom, Level 1Open

    Others

    Inspirational Fireside Chat: In Conversation with Joshua Fink

    Summit StageKavkasioni Ballroom, Level 1Open

    About this session

    Biotechnology is opening new possibilities to treat disease, improve quality of life, and help people live longer in good health. For investors and founders, the opportunity spans scientific breakthroughs, new approaches to drug development, and growing demand for better medicines. In this fireside conversation, Joshua Fink, explores the forces shaping the biotech industry, what it takes to build successful companies, and how Luma Group approaches the space. The discussion will connect the investment opportunity with the ultimate goal of bringing better treatments to more patients around the world.